以天然产物作为药物发现的基础。
Natural Products as a Foundation for Drug Discovery.
作者信息
Beutler John A
机构信息
Molecular Targets Development Program Center for Cancer Research National Cancer Institute Frederick, MD 21702 USA
出版信息
Curr Protoc Pharmacol. 2009 Sep 1;46:9.11.1-9.11.21. doi: 10.1002/0471141755.ph0911s46.
Abstract
Natural products have contributed to the development of many drugs for diverse indications. While most U.S. pharmaceutical companies have reduced or eliminated their in-house natural product groups, new paradigms and new enterprises have evolved to carry on a role for natural products in the pharmaceutical industry. Many of the reasons for the decline in popularity of natural products are being addressed by the development of new techniques for screening and production. This overview aims to inform pharmacologists of current strategies and techniques that make natural products a viable strategic choice for inclusion in drug discovery programs.
摘要
天然产物推动了许多用于各种适应症的药物的研发。尽管大多数美国制药公司已经缩减或裁撤了其内部的天然产物团队，但新的模式和新企业已经涌现，以在制药行业中继续发挥天然产物的作用。天然产物受欢迎程度下降的许多原因正通过筛选和生产新技术的开发得到解决。本综述旨在让药理学家了解当前的策略和技术，这些策略和技术使天然产物成为药物发现计划中可行的战略选择。
相似文献
1
Natural Products as a Foundation for Drug Discovery.
Curr Protoc Pharmacol. 2009 Sep 1;46:9.11.1-9.11.21. doi: 10.1002/0471141755.ph0911s46.
2
Natural Products as a Foundation for Drug Discovery.
Curr Protoc Pharmacol. 2019 Sep;86(1):e67. doi: 10.1002/cpph.67.
3
Natural products as a foundation for drug discovery.
Curr Protoc Pharmacol. 2009 Sep;Chapter 9:Unit 9.11. doi: 10.1002/0471141755.ph0911s46.
4
[Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Theriaca. 2016(43):9-61.
5
Rediscovering natural products as a source of new drugs.
Discov Med. 2005 Apr;5(26):159-64.
6
Exploiting new approaches for natural product drug discovery in the biotechnology industry.
Drug Discov Today Technol. 2005 Autumn;2(3):281-6. doi: 10.1016/j.ddtec.2005.08.002.
7
Modern Approaches in the Discovery and Development of Plant-Based Natural Products and Their Analogues as Potential Therapeutic Agents.
Molecules. 2022 Jan 6;27(2):349. doi: 10.3390/molecules27020349.
8
Drug discovery from natural products - Old problems and novel solutions for the treatment of neurodegenerative diseases.
J Pharm Biomed Anal. 2022 Feb 20;210:114553. doi: 10.1016/j.jpba.2021.114553. Epub 2021 Dec 24.
9
Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections.
Lancet Infect Dis. 2017 Feb;17(2):e30-e41. doi: 10.1016/S1473-3099(16)30323-1. Epub 2016 Dec 13.
10
The value of nature's natural product library for the discovery of New Chemical Entities: the discovery of ingenol mebutate.
Fitoterapia. 2014 Oct;98:36-44. doi: 10.1016/j.fitote.2014.07.002. Epub 2014 Jul 10.
引用本文的文献
1
Pharmacoinformatics in identifying therapeutically important chemical species from Ayurvedic formulations employed in treating COVID-19 patients.
J Ayurveda Integr Med. 2025 Jun 23;16(4):101161. doi: 10.1016/j.jaim.2025.101161.
2
Uvarinol and Dichamanetin Derived from as Potential Dual-Site Inhibitors Against PBP2a in Methicillin Resistant : An In Silico Study.
Pharmaceuticals (Basel). 2025 Apr 4;18(4):529. doi: 10.3390/ph18040529.
3
Discovery of Novel Multiangiogenic Agents Targeting VEGFR2, EphB4, FGFR-1, and TIE-2: Receptor-Based Pharmacophore Modeling, Virtual Screening, and Molecular Modeling Studies.
ACS Omega. 2025 Apr 1;10(14):13880-13897. doi: 10.1021/acsomega.4c08366. eCollection 2025 Apr 15.
4
High-throughput protein crystallography to empower natural product-based drug discovery.
Acta Crystallogr F Struct Biol Commun. 2025 May 1;81(Pt 5):179-192. doi: 10.1107/S2053230X25001542. Epub 2025 Apr 16.
5
The Antibacterial Activity of Yeasts from Unique Biocenoses.
Acta Naturae. 2024 Oct-Dec;16(4):95-104. doi: 10.32607/actanaturae.27527.
6
Exploring and Nematode Symbionts in Search of Novel Therapeutics.
Molecules. 2024 Oct 31;29(21):5151. doi: 10.3390/molecules29215151.
7
Family Malvaceae: a potential source of secondary metabolites with chemopreventive and anticancer activities supported with pharmacokinetic and pharmacodynamic profiles.
Front Pharmacol. 2024 Oct 16;15:1465055. doi: 10.3389/fphar.2024.1465055. eCollection 2024.
8
Molecularly Imprinted Microspheres in Active Compound Separation from Natural Product.
Molecules. 2024 Aug 26;29(17):4043. doi: 10.3390/molecules29174043.
9
Black soldier fly ( L.): A potential small mighty giant in the field of cosmeceuticals.
Health Sci Rep. 2024 Jun 2;7(6):e2120. doi: 10.1002/hsr2.2120. eCollection 2024 Jun.
10
NP MS Workflow: An Open-Source Software System to Empower Natural Product-Based Drug Discovery Using Untargeted Metabolomics.
Anal Chem. 2024 May 14;96(19):7460-7469. doi: 10.1021/acs.analchem.3c05829. Epub 2024 May 3.
本文引用的文献
1
Asymmetric Synthesis of Bryostatin 2.
Angew Chem Int Ed Engl. 1998 Sep 18;37(17):2354-2359. doi: 10.1002/(SICI)1521-3773(19980918)37:17<2354::AID-ANIE2354>3.0.CO;2-9.
2
Exploiting new approaches for natural product drug discovery in the biotechnology industry.
Drug Discov Today Technol. 2005 Autumn;2(3):281-6. doi: 10.1016/j.ddtec.2005.08.002.
3
Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal.
Phytomedicine. 1996 Nov;3(3):281-5. doi: 10.1016/S0944-7113(96)80067-5.
4
Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need.
Mol Interv. 2008 Dec;8(6):284-93. doi: 10.1124/mi.8.6.6.
5
Evolving trends in the dereplication of natural product extracts: new methodology for rapid, small-scale investigation of natural product extracts.
J Nat Prod. 2008 Sep;71(9):1595-9. doi: 10.1021/np8002222. Epub 2008 Aug 19.
6
Marine chemical ecology.
Nat Prod Rep. 2008 Aug;25(4):662-95. doi: 10.1039/b702742g. Epub 2008 Jun 9.
7
Pre-fractionated microbial samples--the second generation natural products library at Wyeth.
Molecules. 2008 Jun 20;13(6):1406-26. doi: 10.3390/molecules13061406.
8
Fractionated marine invertebrate extract libraries for drug discovery.
Molecules. 2008 Jun 19;13(6):1372-83. doi: 10.3390/molecules13061372.
9
Natural products to drugs: natural product-derived compounds in clinical trials.
Nat Prod Rep. 2008 Jun;25(3):475-516. doi: 10.1039/b514294f. Epub 2008 May 7.
10
Efficient synthetic access to a new family of highly potent bryostatin analogues via a Prins-driven macrocyclization strategy.
J Am Chem Soc. 2008 May 28;130(21):6658-9. doi: 10.1021/ja8015632. Epub 2008 May 2.
Zotero 插件